AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (2.9 MB)
Collect
AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Original Article | Open Access

Astragalus membranaceus (Fisch.) Bge. administered by dissolving microneedles achieves systemic therapeutic effects at low doses

Yiwen ChenaZihan ZhouaLuzheng ZhangbZifan DingaPengyue LicCong Yana( )
School of Life Sciences, Beijing University of Chinese Medicine, Beijing 102488, China
Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100029, China
School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102488, China

Peer review under responsibility of Beijing University of Chinese Medicine.

Show Author Information

Abstract

Objective

To determine the main components of Astragalus membranaceus (Fisch.) Bge (A. membranaceus, Huang Qi), Astragaloside Ⅳ (AⅣ) and Astragalus polysaccharides (AP), to characterize their properties, evaluate their in vivo efficacy, and to analyze drug diffusion using dissolving microneedle (DMN) technology in vivo.

Methods

Respectively, AⅣ- and AP-loaded DMNs comprising chitosan (CTS) and polyvinyl alcohol (PVA) were prepared via dual-mold forming. Their morphology, mechanical properties, in vivo solubility, and skin irritation characteristics were tested. In vivo efficacy was assessed in cyclophosphamide-induced immunosuppressed mice, in vivo diffusion of AⅣ and AP by DMNs and conventional methods was compared, and the rheological properties of AⅣ-CTS-PVA and AP-CTS-PVA mixtures were measured.

Results

Subcutaneous dissolution and absorption of AⅣ-CTS-PVA and AP-CTS-PVA microneedles (MNs) at low doses (50%–17% of intraperitoneal AⅣ injection and 12%–4% of intravenous AP injection) reduced the spleen index and acid phosphatase activity in immunosuppressed mouse models, increased the thymus index, and achieved equivalent or better systemic therapeutic effects. Compared with injections, AⅣ and AP achieved controllable solid-liquid conversion through delivery with CTS-PVA MNs, resulting in highly localized aggregation within 48 h, reducing the initial explosive effect of the drug, and achieving stable and slow drug release.

Conclusion

The present study enhances our understanding of the efficacy and remote effects of drug-loaded DMNs from a traditional Chinese medicine (TCM) perspective, thereby promoting the development of precise and efficient delivery of TCM and further expanding the drug-loading range and application scenarios for DMNs.

References

1

Zhang Y, Wang S, Yang Y, et al. Scarless wound healing programmed by core-shell microneedles. Nat Commun. 2023;14(1):3431.

2

Li Y, Chen K, Pang Y, et al. Multifunctional microneedle patches via direct ink drawing of nanocomposite inks for personalized transdermal drug delivery. ACS Nano. 2023;17(20):19925–19937.

3

Huang Y, Li J, Wang Y, et al. Intradermal delivery of an angiotensin Ⅱ receptor blocker using a personalized microneedle patch for treatment of hypertrophic scars. Biomater Sci. 2023;11(2):583–595.

4

Song L, Chi J, Li Z, et al. An inflammation-responsive double-layer microneedle patch for recurrent atopic dermatitis therapy. Int J Pharm. 2023;643:123215.

5

Chen J, Ren H, Zhou P, et al. Microneedle-mediated drug delivery for cutaneous diseases. Front Bioeng Biotechnol. 2022;10:1032041.

6

Lee BM, Lee C, Lahiji SF, et al. Dissolving microneedles for rapid and painless local anesthesia. Pharmaceutics. 2020;12(4):366.

7

Lin Y, Chen Y, Deng R, et al. Delivery of neutrophil membrane encapsulated non-steroidal anti-inflammatory drugs by degradable biopolymer microneedle patch for rheumatoid arthritis therapy. Nano Today. 2023;49:101791.

8

Kim S, Yang H, Eum J, et al. Implantable powder-carrying microneedles for transdermal delivery of high-dose insulin with enhanced activity. Biomaterials. 2020;232:119733.

9

Zhu M, Liu Y, Jiang F, et al. Combined silk fibroin microneedles for insulin delivery. ACS Biomater Sci Eng. 2020;6(6):3422–3429.

10

Zhao J, Xu G, Yao X, et al. Microneedle-based insulin transdermal delivery system: current status and translation challenges. Drug Deliv Transl Res. 2022;12(10):2403–2427.

11

Chen Z, Liu L, Gao C, et al. Astragali Radix (Huangqi): a promising edible immunomodulatory herbal medicine. J Ethnopharmacol. 2020;258:112895.

12

Zheng Y, Ren W, Zhang L, et al. A review of the pharmacological action of Astragalus polysaccharide. Front Pharmacol. 2020;11:349.

13

Yao M, Zhang L, Wang L. Astragaloside Ⅳ: a promising natural neuroprotective agent for neurological disorders. Biomed Pharmacother. 2023;159:114229.

14

Nguyen LTH, Nguyen UT, Kim YH, Shin HM, Yang IJ. Astragali Radix and its compound formononetin ameliorate diesel particulate matter-induced skin barrier disruption by regulation of keratinocyte proliferation and apoptosis. J Ethnopharmacol. 2019;228:132–141.

15

Kim H. Using Astragalus membranaceus (Fisch) Bge. to treat skin diseases: comparison of traditional uses and research results. Planta Med. 2022;88:354.

16

Luo H, Tang QL, Shang YX, et al. Can Chinese medicine be used for prevention of corona virus disease 2019 (COVID-19)? a review of historical classics, research evidence and current prevention programs. Chin J Integr Med. 2020;26(4):243–250.

17

Du Y, Wan H, Huang P, Yang J, He Y. A critical review of Astragalus polysaccharides: from therapeutic mechanisms to pharmaceutics. Biomed Pharmacother. 2022;147:112654.

18

Li Z, Yang W, Yang Y, et al. The Astragaloside Ⅳ derivative LS-102 ameliorates obesity-related nephropathy. Drug Des Dev Ther. 2022;16:647–664.

19

Wang Y, Zhang Q, Chen Y, et al. Antitumor effects of immunity-enhancing traditional Chinese medicine. Biomed Pharmacother. 2020;121:109570.

20

Zhang W, Zhang L, Zhou H, et al. Astragaloside Ⅳ alleviates infarction induced cardiomyocyte injury by improving mitochondrial morphology and function. Front Cardiovasc Med. 2022;9:810541.

21

Liang J, Yang C, Li P, et al. Astragaloside Ⅳ inhibits AOM/DSS-induced colitis-associated tumorigenesis via activation of PPARγ signaling in mice. Phytomedicine. 2023;121:155116.

22

Wang CH, Lin CY, Chen JS, et al. Karnofsky performance status as a predictive factor for cancer-related fatigue treatment with Astragalus polysaccharides (PG2) injection-a double blind, multi-center, randomized phase Ⅳ study. Cancers (Basel). 2019;11(2):128.

23

Usach I, Martinez R, Festini T, Prime-Esteban Peris J. Subcutaneous injection of drugs: literature review of factors influencing pain sensation at the injection site. Adv Ther. 2019;36(11):2986–2996.

24

Wei XC, Cao B, Luo CH, et al. Recent advances of novel technologies for quality consistency assessment of natural herbal medicines and preparations. Chin Med. 2020;15:56.

25

Wang J, Chen Y, Li T, et al. Phellodendri chinensis cortex-based nanoparticles integrated in dissolvable microneedles for ameliorating psoriasis-like inflammation. J Biomed Nanotechnol. 2022;18(9):2227–2239.

26

He R, Niu Y, Li Z, et al. A hydrogel microneedle patch for point-of-care testing based on skin interstitial fluid. Adv Healthcare Mater. 2020;9(4):1901201.

27

Dathathri E, Lal S, Mittal M, Thakur G, De S. Fabrication of low-cost composite polymer-based micro needle patch for transdermal drug delivery. Appl Nanosci. 2020;10(2):371–377.

28

Li Q, Wu T, Shi L, Yin T, Wang B, Hu L. The quality of Astragalus membranaceus from different origins and the effect of storage on its components. The Food Industry. 2024;45(1):323-328 [Chinese].

29
Wang C. Basic Skills in Animal Operation in Basic Medical Experiments. Beijing, China: China Medical Science Press;2009 [Chinese].
30
Li J, Zeng Y, Histology and Embryology. Beijing, China: People’s Medical Publishing House; 2018 [Chinese].
31

Zule WA, Pande PG, Otiashvili D, et al. Options for reducing HⅣ transmission related to the dead space in needles and syringes. Harm Reduct J. 2018;15(1):3.

32

Yan G, Warner KS, Zhang J, Sharma S, Gale BK. Evaluation needle length and density of microneedle arrays in the pretreatment of skin for transdermal drug delivery. Int J Pharm. 2010;391(1):7–12.

33

Fava A, Petri M. Systemic lupus erythematosus: diagnosis and clinical management. J Autoimmun. 2019;96:1–13.

34

Abdelhamid L, Cabana-Puig X, Mu Q, et al. Quaternary ammonium compound disinfectants reduce lupus-associated splenomegaly by targeting neutrophil migration and T-cell fate. Front Immunol. 2020;11:575179.

35

Cooray S, Price-Kuehne F, Hong Y, et al. Neuroinflammation, autoinflammation, splenomegaly and anemia caused by bi-allelic mutations in IRAK4. Front Immunol. 2023;14:1231749.

36

Niu Y, Dong J, Jiang H, et al. Effects of polysaccharide from Malus halliana koehne flowers in cyclophosphamide-induced immunosuppression and oxidative stress on mice. Oxid Med Cell Longev. 2020;2020:1–10.

37

Al-Samkari H, Berliner N. Hemophagocytic lymphohistiocytosis. Annu Rev Pathol Mech Dis. 2018;13(1):27–49.

38

Li HY, Chen LL, Li Y, Li QJ, Liu SR. Effect of Astragalus polysaccharide on intestinal mucosal immunity in immunosuppressed mice. Chin J Clin Pharmacol. 2020;36(21):3465-3468 [Chinese].

39

Yao J, Liu J, He Y, et al. Systems pharmacology reveals the mechanism of Astragaloside Ⅳ in improving immune activity on cyclophosphamide-induced immunosuppressed mice. J Ethnopharmacol. 2023;313:116533.

40

Zhang X, Li X, Ma W, et al. Astragaloside Ⅳ restores Th17/Treg balance via inhibiting CXCR4 to improve chronic obstructive pulmonary disease. Immunopharmacol Immunotoxicol. 2023;45(6):682–691.

41

Li Y, Zheng J, Wang Y, et al. Immuno-stimulatory activity of Astragalus polysaccharides in cyclophosphamide-induced immunosuppressed mice by regulating gut microbiota. Int J Biol Macromol. 2023;242:124789.

42

Guo Z, Qi P, Pei D, Zhang X. Raloxifene-loaded solid lipid nanoparticles decorated gel with enhanced treatment potential of osteoporosis. J Drug Deliv Sci Technol. 2022;75:103733.

43

Chen D, Zhang Y, Chen X, et al. Hydrogel-crosslinked microneedles based on microwave-assisted drying method. Adv Polym Technol. 2022;2022:e2220918.

44

Xu L, Wei K, Jiang J, Zhang L. Extraction optimization of Astragaloside Ⅳ by response surface methodology and evaluation of its stability during sterilization and storage. Molecules. 2021;26(8):2400.

45

Weiss J, Salminen H, Moll P, Schmitt C. Use of molecular interactions and mesoscopic scale transitions to modulate protein-polysaccharide structures. Adv Colloid Interface Sci. 2019;271:101987.

46

Bostanudin MF, Lalatsa A, Gorecki DC, Barbu E. Engineering butylglyceryl-modified polysaccharides towards nanomedicines for brain drug delivery. Carbohydr Polym. 2020;236:116060.

47

Cheng W, Wang BH, Wang WF, Wang B, Zhao XY, Gao YY. Molecular dynamics simulation on effect of temperature and pressure on viscoelasticity of polyurethane elastomers. Acta Polym Sin. 2023;54(3):398–408.

48

Zhang K, Liu Y, Shi X, et al. Application of polyvinyl alcohol/chitosan copolymer hydrogels in biomedicine: a review. Int J Biol Macromol. 2023;242:125192.

49

Chen H, Zeng J, Wang B, et al. Structural characterization and antioxidant activities of Bletilla striata polysaccharide extracted by different methods. Carbohydr Polym. 2021;266:118149.

50

Jie Y, Chen F. Key role of three-dimensional reticular interface membranes in the formation of single polysaccharide–stabilized high internal phase emulsions. Food Hydrocolloids. 2023;144:109021.

51

Li J, Wang H, Li Y. Impact of the thermal motion of silicon atoms on the viscosity of nanoconfined aqueous NaCl solution. Mod Phys Lett B. 2018;32:1850200.

52

Chandrasekharan A, Hwang YJ, Seong KY, Park S, Kim S, Yang SY. Acid-treated water-soluble chitosan suitable for microneedle-assisted intracutaneous drug delivery. Pharmaceutics. 2019;11(5):209.

53

Chi J, Zhang X, Chen C, Shao C, Zhao Y, Wang Y. Antibacterial and angiogenic chitosan microneedle array patch for promoting wound healing. Bioact Mater. 2020;5(2):253–259.

54

Damiri F, Kommineni N, Ebhodaghe SO, et al. Microneedle-based natural polysaccharide for drug delivery systems (DDS): progress and challenges. Pharmaceuticals. 2022;15(2):190.

55

Huang CR, Wang GJ, Wu XL, et al. Absorption enhancement study of Astragaloside Ⅳ based on its transport mechanism in Caco-2 cells. Eur J Drug Metab Pharmacokinet. 2006;31(1):5–10.

56

Sabbagh F, Kim BS. Ex Vivo Transdermal delivery of nicotinamide mononucleotide using polyvinyl alcohol microneedles. Polymers (Basel). 2023;15(9):2031.

57

Shamana H, Grossutti M, Papp-Szabo E, Miki C, Dutcher JR. Unusual polysaccharide rheology of aqueous dispersions of soft phytoglycogen nanoparticles. Soft Matter. 2018;14(31):6496–6505.

58

Chalykh AE, Petrova TF, Matveev VV, et al. Phase equilibria and structures of phases in the chitosan-polyvinyl alcohol systems. Russ Chem Bull. 2020;69(4):675–682.

59

Harvey AJ, Kaestner SA, Sutter DE, et al. Microneedle-based intradermal delivery enables rapid lymphatic uptake and distribution of protein drugs. Pharm Res. 2011;28(1):107–116.

60

You J, Yang C, Han J, et al. Ultrarapid-acting microneedles for immediate delivery of biotherapeutics. Adv Mater. 2023;35(45):e2304582.

61

An H, Gu Z, Huang Z, et al. Novel microneedle platforms for the treatment of wounds by drug delivery: a review. Colloids Surf B Biointerfaces. 2024;233:113636.

62

Zhu Y, Chen Y. On the acupoint medicine effect of acupoint injection. Chin Acupunct Moxibustion. 2005(1):50-52 [Chinese].

63

Zhao Y, Ma H, Cai D. Progress in clinical and mechanistic research on acupoint thread embedding and acupoint injection. Modern J Integr Tradit Chin West Med. 2013;22(7):784-787 [Chinese].

64

Liang H. Exogenous febrile disease to see first biao signs, the barriers of Liujing result in Taiyang – taiyang get a sick. Acta Chin Med. 2012;27(3):293-295 [Chinese].

65

Yao F, Zhao Y, Jiang S, Fang M. Theoretical basis for the treatment of chronic fatigue syndrome based on the bladder meridian of foot-Taiyang. Chin Acupunct Moxibustion. 2015;35(3):295-298 [Chinese].

66

Lu W, Yuan J. Clinical experience in treating stubborn insomnia with back acupoint flat and penetrating acupuncture method. Asia Pac Tradit Med. 2020;16(11):93-95 [Chinese].

67

Roberts MS, Cheruvu HS, Mangion SE, et al. Topical drug delivery: history, percutaneous absorption, and product development. Adv Drug Deliv Rev. 2021;177:113929.

68

Khatoon M, Shah KU, Din FU, et al. Proniosomes derived niosomes: recent advancements in drug delivery and targeting. Drug Deliv. 2017;24(suppl 1):56–69.

69

Shi Q, Kuether EL, Schroeder JA, Fahs SA, Montgomery RR. Intravascular recovery of VWF and FⅧ following intraperitoneal injection and differences from intravenous and subcutaneous injection in mice. Haemophilia. 2012;18(4):639–646.

70

Dou S, Smith M, Wang Y, Rusckowski M, Liu G. Intraperitoneal injection is not always a suitable alternative to intravenous injection for radiotherapy. Cancer Biother Radiopharm. 2013;28(4):335–342.

71

Wang N, Shao Y, Mei Y, et al. Novel mechanism for mesenchymal stem cells in attenuating peritoneal adhesion: accumulating in the lung and secreting tumor necrosis factor α-stimulating gene-6. Stem Cell Res Ther. 2012;3(6):51.

72

Yang H, Wu X, Zhou Z, Chen X, Kong M. Enhanced transdermal lymphatic delivery of doxorubicin via hyaluronic acid based transfersomes/microneedle complex for tumor metastasis therapy. Int J Biol Macromol. 2019;125:9–16.

73

Niu L, Chu LY, Burton SA, Hansen KJ, Panyam J. Intradermal delivery of vaccine nanoparticles using hollow microneedle array generates enhanced and balanced immune response. J Contr Release. 2019;294:268–278.

74

Ekanger LA, Polin LA, Shen Y, Haacke EM, Allen MJ. Evaluation of Eu (Ⅱ)-based positive contrast enhancement after intravenous, intraperitoneal, and subcutaneous injections. Contrast Media Mol Imaging. 2016;11(4):299–303.

Journal of Traditional Chinese Medical Sciences
Pages 340-350
Cite this article:
Chen Y, Zhou Z, Zhang L, et al. Astragalus membranaceus (Fisch.) Bge. administered by dissolving microneedles achieves systemic therapeutic effects at low doses. Journal of Traditional Chinese Medical Sciences, 2024, 11(3): 340-350. https://doi.org/10.1016/j.jtcms.2024.05.007

110

Views

4

Downloads

0

Crossref

0

Scopus

Altmetrics

Received: 11 March 2024
Revised: 31 May 2024
Accepted: 31 May 2024
Published: 05 June 2024
© 2024 Beijing University of Chinese Medicine.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Return